Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation

Summary

This will be a double-blind, randomized, placebo-controlled, parallel group study. The purpose of this study is to investigate the efficacy and safety of Cavosonstat (N91115) in adult patients with CF who are homozygous for the F508del-CFTR mutation and being treated with lumacaftor/ivacaftor (Orkambi™).

Timeline

Start

2015-11

Primary completion

2016-12

Completion

2016-12

Drugs

Indications